This year marks the 40th anniversary of the cardiothoracic surgery organization, and it has a big celebration planned.

The expert consensus decision pathway goes beyond the guidelines to provide practice advice around BP management.

The evolving data now show clear biological efficacy with impact on hard clinical outcomes, says Sahil Parikh.

The observational Swedish data need to be further explored but may have identified a new screening target in stroke ...

This year marks the 40th anniversary of the cardiothoracic surgery organization, and it has a big celebration planned.

From PAD to pulmonary embolism and stroke, the meeting promises to be packed with cutting-edge vascular therapy news.

Two new observational studies add to the growing evidence base on cardiovascular risks associated with hormone replacement ...

The Autus surgically implanted device, made by Edwards Lifesciences, is also novel for its leaflets consisting of ePTFE.

A key message is that clinicians need to include nutrition discussions as part of routine care, Frank Hu says.

Experts urge clinicians to focus on stroke prevention benefits when counseling patients about carotid revascularization.

Mavacamten (Camzyos) is now approved by the US Food and Drug Administration for use not only in adults, but also in pediatric patients with obstructive hypertrophic cardiomyopathy (HCM) who weigh at ...